Skip to main content
TipRanks
Go Ultimate75% OFF

Orient Pharma Co., Ltd. (4166) Q3 2026 Earnings Report

TW:4166 Q3 2026 EPS Results

Actual EPS
TWD 0.31
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
TWD 0.21

TW:4166 Q3 2026 Revenue Results

Actual Revenue
TWD 396.58M
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
+25.45%

Earnings Announcement Details

Quarter
Q3 2026
Date
11/17/2026
Time
TBA
Conference Call
Tuesday, November 17, 2026

Q3 2026 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q3 2026 Earnings Slide Deck

No slide deck is available for this earnings event.

Q3 2026 Earnings Call Summary

No earnings call summary is available for this earnings event.

TW:4166 Earnings History

TW:4166 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Nov 17, 20262026 (Q3)―0.310.2149.52% (+0.10)
Aug 11, 20262026 (Q2)―0.240.08180.95% (+0.15)
May 13, 20262026 (Q1)―0.160.23-29.96% (-0.07)
Feb 25, 20262025 (Q4)―0.380.05721.74% (+0.33)
Nov 11, 20252025 (Q3)―0.210.43-51.72% (-0.23)
Aug 13, 20252025 (Q2)―0.080.43-80.69% (-0.35)
May 14, 20252025 (Q1)―0.230.1129.29% (+0.13)
Mar 24, 20252024 (Q4)―0.050.1-53.54% (-0.05)
Aug 13, 20242024 (Q2)―0.43043400.00% (+0.43)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed